@article{44233a985203446eb1335ab7579d51a1,
title = "Classical Hodgkin Lymphoma: From Past to Future{\textemdash}A Comprehensive Review of Pathophysiology and Therapeutic Advances",
keywords = "Hodgkin lymphoma, brentuximab, checkpoint inhibitors, chimeric antigen T cells, new drugs, targeted therapy, Hodgkin Disease/drug therapy, Humans, Neoplasms, Second Primary/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Leukemia/drug therapy, Adult, Child",
author = "Faryal Munir and Viney Hardit and Sheikh, \{Irtiza N.\} and Shaikha AlQahtani and Jiasen He and Branko Cuglievan and Chitra Hosing and Priti Tewari and Sajad Khazal",
note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",
year = "2023",
month = jun,
doi = "10.3390/ijms241210095",
language = "English",
volume = "24",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
number = "12",
}